KHK Pharmaceuticals Private Limited
About KHK Pharmaceuticals Private Limited
Data last updated:
KHK Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC280163. Its GSTIN is 07AAFCK8174R1ZN (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sohail Abbas and Nayeem Ahmad Siddiqui.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at H. No. 156A Second Floor, Sarai Jullena, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2023, the company reported a revenue of ₹47.22 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹60,262 (net margin 1.3%) and EBITDA of ₹81,435 (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 76% over three years and 47% over five years.
The company is associated with 1 brand: KHK Pharma.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH. No. 156A Second Floor, Sarai Jullena, New Delhi, Delhi, India – 110025
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of KHK Pharmaceuticals Private Limited
The main business activity of KHK Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of KHK Pharmaceuticals Private Limited FY 2023 filings available
KHK Pharmaceuticals Private Limited reported revenue of ₹47.22 Lakh (up 183% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of KHK Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 47% over five years, including 183% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of KHK Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹47.22 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹81,435 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹60,262 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of KHK Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of KHK Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of KHK Pharmaceuticals Private Limited
KHK Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Macmantus Pharmaceuticals Private Limited | ₹47.3 Lakh (FY 2023) | •••• | •••• | •••• | Gwalior, Madhya Pradesh, India | |
| Accurel Pharmaceuticals Private Limited | ₹47.27 Lakh (FY 2025) | •••• | •••• | -47.0% | •••• | Mumbai, Maharashtra, India |
| Jivan Sambridhi Pharmaceuticals Private Limited | ₹47.25 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Kolkata, West Bengal, India |
| Navda Healthcare Limited | ₹47.24 Lakh (FY 2018) | •••• | •••• | 320.0% | •••• | Chandrapur, Maharashtra, India |
| Velchi Pharma Private Limited | ₹47.22 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| KHK Pharmaceuticals Private Limited this company | ₹47.22 Lakh (FY 2023) | •••• | •••• | 183.0% | •••• | New Delhi, Delhi, India |
| Inverse Pharmaceuticals Private Limited | ₹47.09 Lakh (FY 2023) | •••• | •••• | 42.0% | •••• | Kanpur, Uttar Pradesh, India |
| Sulzderma Pharmaceuticals Private Limited | ₹47.07 Lakh (FY 2024) | •••• | •••• | -8.0% | •••• | Nagpur, Maharashtra, India |
| Amcare Biosciences Private Limited | ₹47.05 Lakh (FY 2025) | •••• | •••• | 277.0% | •••• | Ahmedabad, Gujarat, India |
| Fidrok Pharmaceuticals Private Limited | ₹47.05 Lakh (FY 2025) | •••• | •••• | 4605.0% | •••• | Gmc, Assam, India |
| RDW Pharmaceuticals Private Limited | ₹47.05 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below KHK Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of KHK Pharmaceuticals Private Limited
KHK Pharmaceuticals Private Limited is audited by QUADRI AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| QUADRI AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of KHK Pharmaceuticals Private Limited
KHK Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sohail Abbas | Director | 12 Jan 2019 | 7 Years 9 Months | Current |
| Nayeem Ahmad Siddiqui Also directs: Dr'hub Multi Speciality Hospital Private Limited | Director | 14 May 2015 | 11 Years 4 Months | Current |
| Moiz Ahmad | Director | 14 May 2015 | 11 Years 4 Months | Current |
Ownership and Shareholding of KHK Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of KHK Pharmaceuticals Private Limited
KHK Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with KHK Pharmaceuticals Private Limited
KHK Pharmaceuticals operates one associated brand: KHK Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and supply of dosage forms in India. | khkpharma.com |
Employees and EPFO Compliance at KHK Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to KHK Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on KHK Pharmaceuticals Private Limited
KHK Pharmaceuticals Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Sohail Abbas was appointed as Director on 12 Jan 2019.
Credit Ratings, Litigation & Regulatory Alerts for KHK Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by KHK Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of KHK Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of KHK Pharmaceuticals Private Limited
KHK Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCK8174R1ZN | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of KHK Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KHK Pharmaceuticals Private Limited
KHK Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 May 2015 (11+ years old) and is registered under CIN U24100DL2015PTC280163.
KHK Pharmaceuticals reported revenue of ₹47.22 Lakh for FY 2023 (up 183% YoY).
KHK Pharmaceuticals has 3 current directors:
- Sohail Abbas - Director
- Nayeem Ahmad Siddiqui - Director
- Moiz Ahmad - Director
KHK Pharmaceuticals reported a net profit of ₹60,262 (net margin 1.3%) and EBITDA of ₹81,435 (EBITDA margin 1.7%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of KHK Pharmaceuticals is 76% over three years and 47% over five years. In the latest year (FY 2023) revenue rose 183%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of KHK Pharmaceuticals is 07AAFCK8174R1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of KHK Pharmaceuticals is U24100DL2015PTC280163. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
KHK Pharmaceuticals was incorporated on 14 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of KHK Pharmaceuticals by revenue are Macmantus Pharmaceuticals Private Limited, Accurel Pharmaceuticals Private Limited, Jivan Sambridhi Pharmaceuticals Private Limited, Navda Healthcare Limited, Velchi Pharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Sohail Abbas was appointed as Director on 12 Jan 2019. Mohd Naiyer Alam ceased to be Director on 13 Mar 2018. Moiz Ahmad was appointed as Director on 14 May 2015. KHK Pharmaceuticals has 4 board changes on record in total.
The registered office of KHK Pharmaceuticals is at H. No. 156A Second Floor, Sarai Jullena, New Delhi, Delhi, India – 110025.